Heartflow, Inc. $HTFL Stock Position Lifted by Alyeska Investment Group L.P.

Alyeska Investment Group L.P. lifted its position in Heartflow, Inc. (NASDAQ:HTFL - Free Report) by 55.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 350,000 shares of the company's stock after acquiring an additional 125,000 shares during the quarter. Alyeska Investment Group L.P. owned 0.40% of Heartflow worth $10,269,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in HTFL. XXEC Inc. bought a new stake in Heartflow during the second quarter valued at $2,524,764,000. Quantinno Capital Management LP bought a new stake in shares of Heartflow during the 1st quarter valued at about $1,734,000. Sei Investments Co. raised its stake in Heartflow by 342.5% during the first quarter. Sei Investments Co. now owns 67,048 shares of the company's stock worth $1,631,000 after acquiring an additional 51,895 shares during the period. Handelsbanken Fonder AB bought a new position in Heartflow in the second quarter worth about $910,000. Finally, BlackRock Inc. acquired a new position in Heartflow in the second quarter valued at approximately $152,502,000.

Heartflow Stock Performance

Shares of HTFL stock opened at $50.39 on Tuesday. The business's fifty day moving average is $32.58 and its 200-day moving average is $29.22. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $51.19. The stock has a market cap of $4.38 billion and a PE ratio of -27.54.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business's revenue for the quarter was up 47.7% compared to the same quarter last year. Equities research analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Insider Buying and Selling at Heartflow

In related news, CEO John C.M. Farquhar sold 27,230 shares of the business's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the transaction, the chief executive officer directly owned 360,814 shares of the company's stock, valued at approximately $18,040,700. The trade was a 7.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the company's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the completion of the transaction, the insider owned 86,459 shares in the company, valued at approximately $3,564,704.57. This represents a 9.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 191,271 shares of company stock valued at $7,089,136. 7.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

HTFL has been the topic of a number of research reports. Weiss Ratings upgraded Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. Freedom Capital upgraded Heartflow to a "strong-buy" rating in a research report on Tuesday, June 30th. Wells Fargo & Company upped their price objective on Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a research note on Friday, August 14th. Stifel Nicolaus raised their target price on Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a research note on Friday, August 14th. Finally, Benchmark reaffirmed a "buy" rating on shares of Heartflow in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $43.43.

Heartflow Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source